申请人:Sociedad Espanola de Especialidades Farmaco-Terapeuticas S.A.
公开号:US05177099A1
公开(公告)日:1993-01-05
Dichloro-substituted 1-(5H-dibenzo[a,d]cyclohepten-5-yl)-1H-imidazole comnds of formula (I), in which --X-- is either --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--, and their pharmaceutically acceptable addition salts, preferably the nitric acid ones. Products of formula (I) are prepared from products of formula (VI) where Z represents a leaving group such as halogen, by treatment with an excess of imidazole in dimethylformamide. Products (I) show an antifungal activity comparable -or superior- to antimycotics in the market, such as Clotrimazole and Bifonazole. ##STR1##
公式(I)中的二氯取代的1-(5H-二苯并[a,d]环庚烯-5-基)-1H-咪唑化合物,其中--X--为--CH.sub.2--CH.sub.2--或--CH.dbd.CH--,以及其药学上可接受的盐,优选为硝酸盐。公式(I)的产物是通过在二甲基甲酰胺中过量使用咪唑处理卤素等离子体,如公式(VI)的产物制备而成。公式(I)的产物表现出与市场上的抗真菌药物(如克霉唑和比福酮)相当或优越的抗真菌活性。